375 related articles for article (PubMed ID: 28651919)
1. ST2 predicts survival in patients undergoing transcatheter aortic valve implantation.
Schmid J; Stojakovic T; Zweiker D; Scharnagl H; Maderthaner RD; Scherr D; Maier R; Schmidt A; März W; Binder JS; Rainer PP
Int J Cardiol; 2017 Oct; 244():87-92. PubMed ID: 28651919
[TBL] [Abstract][Full Text] [Related]
2. Soluble ST2 for Risk Stratification and the Prediction of Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation.
Stundl A; Lünstedt NS; Courtz F; Freitag-Wolf S; Frey N; Holdenrieder S; Zur B; Grube E; Nickenig G; Werner N; Frank D; Sinning JM
Am J Cardiol; 2017 Sep; 120(6):986-993. PubMed ID: 28739033
[TBL] [Abstract][Full Text] [Related]
3. Soluble ST2 predicts 1-year outcome in patients undergoing transcatheter aortic valve implantation.
Wernly B; Lichtenauer M; Jirak P; Eder S; Reiter C; Kammler J; Kypta A; Jung C; Franz M; Hoppe UC; Landmesser U; Figulla HR; Lauten A
Eur J Clin Invest; 2017 Feb; 47(2):149-157. PubMed ID: 28036122
[TBL] [Abstract][Full Text] [Related]
4. Elevated growth differentiation factor 15 levels predict outcome in patients undergoing transcatheter aortic valve implantation.
Krau NC; Lünstedt NS; Freitag-Wolf S; Brehm D; Petzina R; Lutter G; Bramlage P; Dempfle A; Frey N; Frank D
Eur J Heart Fail; 2015 Sep; 17(9):945-55. PubMed ID: 26230285
[TBL] [Abstract][Full Text] [Related]
5. Insulin like growth factor binding protein 2 (IGFBP-2) for risk prediction in patients with severe aortic stenosis undergoing Transcatheter Aortic Valve Implantation (TAVI).
Muessig JM; Lichtenauer M; Wernly B; Kelm M; Franz M; Bäz L; Schulze PC; Racher V; Zimmermann G; Figulla HR; Paar V; Hoppe UC; Rouet P; Lauten A; Jung C
Int J Cardiol; 2019 Feb; 277():54-59. PubMed ID: 30309683
[TBL] [Abstract][Full Text] [Related]
6. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement.
Lindman BR; Breyley JG; Schilling JD; Vatterott AM; Zajarias A; Maniar HS; Damiano RJ; Moon MR; Lawton JS; Gage BF; Sintek MA; Aquino A; Holley CL; Patel NM; Lawler C; Lasala JM; Novak E
Heart; 2015 Sep; 101(17):1382-8. PubMed ID: 26037104
[TBL] [Abstract][Full Text] [Related]
7. The integrated value of sST2 and global longitudinal strain in the early stratification of patients with severe aortic valve stenosis: a translational imaging approach.
Fabiani I; Conte L; Pugliese NR; Calogero E; Barletta V; Di Stefano R; Santoni T; Scatena C; Bortolotti U; Naccarato AG; Petronio AS; Di Bello V
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1915-1920. PubMed ID: 28664478
[TBL] [Abstract][Full Text] [Related]
8. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
[TBL] [Abstract][Full Text] [Related]
9. Multi-biomarker analysis in patients after transcatheter aortic valve implantation (TAVI).
Mirna M; Wernly B; Paar V; Jung C; Jirak P; Figulla HR; Kretzschmar D; Franz M; Hoppe UC; Lichtenauer M; Lauten A
Biomarkers; 2018 Dec; 23(8):773-780. PubMed ID: 30041555
[TBL] [Abstract][Full Text] [Related]
10. The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.
Bouleti C; Chauvet M; Franchineau G; Himbert D; Iung B; Alos B; Brochet E; Urena M; Ghodbane W; Ou P; Provenchere S; Nataf P; Vahanian A
Eur J Cardiothorac Surg; 2017 Jan; 51(1):80-88. PubMed ID: 27582074
[TBL] [Abstract][Full Text] [Related]
11. A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1,141 patients with severe symptomatic aortic stenosis and less than high risk.
Schymik G; Heimeshoff M; Bramlage P; Herbinger T; Würth A; Pilz L; Schymik JS; Wondraschek R; Süselbeck T; Gerhardus J; Luik A; Gonska BD; Tzamalis P; Posival H; Schmitt C; Schröfel H
Catheter Cardiovasc Interv; 2015 Oct; 86(4):738-44. PubMed ID: 25641398
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of a new left bundle branch block following TAVI implantation: 1-year results of the TAVIK cohort.
Schymik G; Tzamalis P; Bramlage P; Heimeshoff M; Würth A; Wondraschek R; Gonska BD; Posival H; Schmitt C; Schröfel H; Luik A
Clin Res Cardiol; 2015 Apr; 104(4):351-62. PubMed ID: 25388650
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 predicts short- and long-term outcome in patients undergoing transcatheter aortic valve implantation (TAVI).
Baldenhofer G; Zhang K; Spethmann S; Laule M; Eilers B; Leonhardt F; Sanad W; Dreger H; Sander M; Grubitzsch H; Baumann G; Stangl K; Stangl V; Knebel F
Int J Cardiol; 2014 Dec; 177(3):912-7. PubMed ID: 25456698
[TBL] [Abstract][Full Text] [Related]
14. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
[TBL] [Abstract][Full Text] [Related]
15. The changing characteristics and outcomes of patients undergoing surgical aortic valve replacement in the transcatheter aortic valve implantation era.
Rozen G; Fefer P; Shinfeld A; Sternik L; Guetta V; Malachy A; Levin S; Feinberg M; Raanani E; Segev A
J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):261-6. PubMed ID: 25004001
[TBL] [Abstract][Full Text] [Related]
16. Red blood cell distribution width as a prognostic factor in patients undergoing transcatheter aortic valve implantation.
Szekely Y; Finkelstein A; Bazan S; Halkin A; Abbas Younis M; Erez J; Keren G; Banai S; Arbel Y
J Cardiol; 2019 Sep; 74(3):212-216. PubMed ID: 31060955
[TBL] [Abstract][Full Text] [Related]
17. Red cell distribution width improves the prediction of prognosis after transcatheter aortic valve implantation.
Collas VM; Paelinck BP; Rodrigus IE; Vrints CJ; Van Craenenbroeck EM; Bosmans JM
Eur J Cardiothorac Surg; 2016 Feb; 49(2):471-7. PubMed ID: 25913826
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of transcatheter aortic valve implantation in high surgical risk and inoperable patients with aortic stenosis: a single Australian Centre experience.
Subban V; Murdoch D; Savage ML; Crowhurst J; Saireddy R; Poon KK; Incani A; Bett N; Burstow DJ; Scalia GM; Clarke A; Raffel OC; Aroney CN; Walters DL
Intern Med J; 2016 Jan; 46(1):42-51. PubMed ID: 26482426
[TBL] [Abstract][Full Text] [Related]
19. Usefulness and validation of the survival posT TAVI score for survival after transcatheter aortic valve implantation for aortic stenosis.
D'Ascenzo F; Capodanno D; Tarantini G; Nijhoff F; Ciuca C; Rossi ML; Brambilla N; Barbanti M; Napodano M; Stella P; Saia F; Ferrante G; Tamburino C; Gasparetto V; Agostoni P; Marzocchi A; Presbitero P; Bedogni F; Cerrato E; Omedè P; Conrotto F; Salizzoni S; Biondi Zoccai G; Marra S; Rinaldi M; Gaita F; D'Amico M; Moretti C
Am J Cardiol; 2014 Dec; 114(12):1867-74. PubMed ID: 25438915
[TBL] [Abstract][Full Text] [Related]
20. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients.
Piazza N; Kalesan B; van Mieghem N; Head S; Wenaweser P; Carrel TP; Bleiziffer S; de Jaegere PP; Gahl B; Anderson RH; Kappetein AP; Lange R; Serruys PW; Windecker S; Jüni P
JACC Cardiovasc Interv; 2013 May; 6(5):443-51. PubMed ID: 23702009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
